⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30464064 | 1.00 | — | — | |
| SCHEMBL1109097 | 1.00 | — | — | |
| SCHEMBL2162300 | 0.76 | — | — | |
| Lactic Acid SCHEMBL18393376 | 0.76 | — | — | |
| SCHEMBL16130111 | 0.75 | — | — | |
| SCHEMBL14932540 | 0.75 | — | — | |
| SCHEMBL13984778 | 0.75 | — | — | |
| SCHEMBL16511510 | 0.75 | — | — | |
| SCHEMBL7899644 | 0.75 | — | — | |
| SCHEMBL14932593 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101045045-A | Medicine composition containing soya bean aglycone and its preparing method | SHANGHAI PHARMACEUTIC INST CHI (CN) | 2007-10-03 | — | — | CN | claimed |
| EP-0935963-A2 | The use of MMP-13 selective inhibitors for the treatment of osteoarthritis and other matrix metalloproteinase-mediated disorders | Pfizer Products Inc. (US) | 1999-08-18 | — | — | EP | claimed |
| EP-0009776-B1 | N-MONOHYDROXYPROPYLAMIDES, N-DIHYDROXYPROPYLAMIDES AND THEIR ACETONOIDES OF ALL-E AND 13-Z RETINOIC ACID, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | BASF Aktiengesellschaft (DE) | 1982-07-28 | — | — | EP | claimed |
| CN-122004216-A | Herbicide composition containing cyclohexene diketone lactic acid oxime ether derivative and application thereof | 郑州手性药物研究院有限公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-122004216-A | Herbicide composition containing cyclohexene diketone lactic acid oxime ether derivative and application thereof | 郑州手性药物研究院有限公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-122004216-A | Herbicide composition containing cyclohexene diketone lactic acid oxime ether derivative and application thereof | 郑州手性药物研究院有限公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-121362146-A | Cyclohexene diketone lactic acid oxime ether compound and preparation method and application thereof | 郑州手性药物研究院有限公司 | 2026-01-20 | — | — | CN | disclosed |
| CN-121362146-A | Cyclohexene diketone lactic acid oxime ether compound and preparation method and application thereof | 郑州手性药物研究院有限公司 | 2026-01-20 | — | — | CN | disclosed |
| CN-114373504-A | Method for evaluating harmful micromolecular sensitization activity generated in fried food processing process | 吉林大学 | 2022-04-19 | — | — | CN | disclosed |
| CN-111328277-A | Method for reshaping keratin fibers | 莱雅公司 | 2020-06-23 | — | — | CN | disclosed |
| CN-111295180-A | Method for reshaping keratin fibers | 莱雅公司 | 2020-06-16 | — | — | CN | disclosed |
| CN-101045045-A | Medicine composition containing soya bean aglycone and its preparing method | SHANGHAI PHARMACEUTIC INST CHI (CN) | 2007-10-03 | — | — | CN | disclosed |
| EP-0935963-A2 | The use of MMP-13 selective inhibitors for the treatment of osteoarthritis and other matrix metalloproteinase-mediated disorders | Pfizer Products Inc. (US) | 1999-08-18 | — | — | EP | disclosed |
| EP-0009776-B1 | N-MONOHYDROXYPROPYLAMIDES, N-DIHYDROXYPROPYLAMIDES AND THEIR ACETONOIDES OF ALL-E AND 13-Z RETINOIC ACID, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | BASF Aktiengesellschaft (DE) | 1982-07-28 | — | — | EP | disclosed |
| EP-0009776-B1 | N-MONOHYDROXYPROPYLAMIDES, N-DIHYDROXYPROPYLAMIDES AND THEIR ACETONOIDES OF ALL-E AND 13-Z RETINOIC ACID, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | BASF Aktiengesellschaft (DE) | 1982-07-28 | — | — | EP | disclosed |
| EP-0009776-A1 | N-monohydroxypropylamides, N-dihydroxypropylamides and their acetonoides of all-E and 13-Z retinoic acid, process for their preparation and pharmaceutical compositions containing them | BASF Aktiengesellschaft (DE) | 1980-04-16 | — | — | EP | disclosed |
| US-4062649-A | Depletion indicator for controlled-release pesticide formulations | SHELL OIL COMPANY (US) | 1977-12-13 | — | — | US | disclosed |